designer491/iStock through Getty Pictures
STAAR Surgical (NASDAQ:STAA) rose 6.5% amid some takeover hypothesis.
The maker of implantable lenses is alleged to have been approached by bigger rival Alcon (ALC), in keeping with a StreetInsider report on Wednesday, which cited an unidentified supply. It isn’t clear if the strategy will result in a deal.
A STAAR Surgical (STAA) spokesperson advised StreetInsider that the corporate has a coverage of not commenting on rumor or hypothesis. Alcon (ALC) additionally advised the publication it has the identical coverage.
The most recent information comes after Betaville final week mentioned that an unidentified European firm is purported to be considering STAAR (STAA) and is working with a financial institution to judge a possible deal.
